[go: up one dir, main page]

DK2024329T3 - (2R) -2 - [(4-SULPHONYL) AMINOPHENYL] PROPANAMIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents

(2R) -2 - [(4-SULPHONYL) AMINOPHENYL] PROPANAMIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Info

Publication number
DK2024329T3
DK2024329T3 DK07729254.8T DK07729254T DK2024329T3 DK 2024329 T3 DK2024329 T3 DK 2024329T3 DK 07729254 T DK07729254 T DK 07729254T DK 2024329 T3 DK2024329 T3 DK 2024329T3
Authority
DK
Denmark
Prior art keywords
propanamids
sulphonyl
aminophenyl
pharmaceutical compositions
compositions containing
Prior art date
Application number
DK07729254.8T
Other languages
Danish (da)
Inventor
Marcello Allegretti
Riccardo Bertini
Cinzia Bizzarri
Maria Candida Cesta
Andrea Aramini
Alessio Moriconi
Original Assignee
Dompe Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa filed Critical Dompe Spa
Application granted granted Critical
Publication of DK2024329T3 publication Critical patent/DK2024329T3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/09Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by at least two halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/14Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DK07729254.8T 2006-05-18 2007-05-17 (2R) -2 - [(4-SULPHONYL) AMINOPHENYL] PROPANAMIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DK2024329T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06114185 2006-05-18
PCT/EP2007/054806 WO2007135080A2 (en) 2006-05-18 2007-05-17 (2r)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
DK2024329T3 true DK2024329T3 (en) 2013-11-04

Family

ID=38353147

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07729254.8T DK2024329T3 (en) 2006-05-18 2007-05-17 (2R) -2 - [(4-SULPHONYL) AMINOPHENYL] PROPANAMIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Country Status (22)

Country Link
US (2) US7652169B2 (en)
EP (1) EP2024329B1 (en)
JP (1) JP5161873B2 (en)
KR (1) KR101422299B1 (en)
CN (1) CN101448784B (en)
AU (1) AU2007253424B2 (en)
BR (1) BRPI0712064B8 (en)
CA (1) CA2649794C (en)
CY (1) CY1114532T1 (en)
DK (1) DK2024329T3 (en)
ES (1) ES2433095T3 (en)
HR (1) HRP20130989T1 (en)
IL (1) IL194939A (en)
MX (1) MX2008013957A (en)
NZ (1) NZ572075A (en)
PL (1) PL2024329T3 (en)
PT (1) PT2024329E (en)
RS (1) RS53007B (en)
RU (1) RU2457201C2 (en)
SI (1) SI2024329T1 (en)
WO (1) WO2007135080A2 (en)
ZA (1) ZA200808907B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2166006A1 (en) * 2008-09-18 2010-03-24 Dompe' S.P.A. 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
KR101298651B1 (en) * 2011-03-16 2013-08-21 연세대학교 산학협력단 Pharmaceutical Compositions for Enhanced Anti-angiogenic Activities
CN103159674A (en) * 2013-04-03 2013-06-19 苏州安诺生物医药技术有限公司 2-benzene alkyl amid compound and preparation method, medical composition and use thereof
US10301378B2 (en) 2013-06-18 2019-05-28 New York University Cellular factors involved in the cytotoxicity of Staphylococcus aureus leukocidins: novel therapeutic targets
RU2017106172A (en) * 2014-07-31 2018-08-28 Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед USE OF CXCR2 ANTAGONISTS TO PREVENT AND / OR TREAT PERIPHERAL NEUROPATHY CAUSED BY CHEMOTHERAPY (CIPN)
WO2021191305A1 (en) 2020-03-26 2021-09-30 Dompe' Farmaceutici Spa Cxcl8 inhibitors for use in the treatment of covid-19
EP3884932A1 (en) 2020-03-26 2021-09-29 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19
EP4008325A1 (en) 2020-12-02 2022-06-08 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN188162B (en) * 1999-02-05 2002-08-31 Torrent Pharmaceuticals Ltd
IT1317826B1 (en) * 2000-02-11 2003-07-15 Dompe Spa AMIDES, USEFUL IN THE INHIBITION OF THE CHEMOTAXIS OF NEUTROPHILES INDUCED BY IL-8.
ITMI20012434A1 (en) * 2001-11-20 2003-05-20 Dompe Spa 2-ARYL-PROPIONIC ACIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP1457485A1 (en) * 2003-03-14 2004-09-15 Dompé S.P.A. Sulfonic acids, their derivatives and pharmaceutical compositions containing them
KR100707123B1 (en) * 2003-07-02 2007-04-16 그뤼넨탈 게엠베하 4-methylsulfonylaminophenyl analogues as vanilloid antagonist showing excellent analgesic activity and the pharmaceutical composition containing the same
ATE444286T1 (en) * 2004-03-23 2009-10-15 Dompe Pha R Ma Spa Res & Mfg 2-PHENYLPROPIONIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
AU2005315591B2 (en) * 2004-12-15 2011-03-17 Dompe' Farmaceutici S.P.A. 2-arylpropionic acid derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
RS53007B (en) 2014-04-30
ES2433095T3 (en) 2013-12-09
SI2024329T1 (en) 2014-01-31
JP2010505742A (en) 2010-02-25
CA2649794A1 (en) 2007-11-29
BRPI0712064B1 (en) 2020-10-20
IL194939A0 (en) 2009-08-03
US7868046B2 (en) 2011-01-11
IL194939A (en) 2015-02-26
EP2024329A2 (en) 2009-02-18
AU2007253424B2 (en) 2013-03-07
MX2008013957A (en) 2008-11-14
EP2024329B1 (en) 2013-07-31
KR101422299B1 (en) 2014-07-22
BRPI0712064A2 (en) 2011-12-20
CA2649794C (en) 2016-02-16
CY1114532T1 (en) 2016-10-05
HK1131380A1 (en) 2010-01-22
KR20090010979A (en) 2009-01-30
JP5161873B2 (en) 2013-03-13
ZA200808907B (en) 2010-03-31
CN101448784A (en) 2009-06-03
BRPI0712064B8 (en) 2021-05-25
RU2008149936A (en) 2010-06-27
PL2024329T3 (en) 2014-03-31
CN101448784B (en) 2012-07-04
RU2457201C2 (en) 2012-07-27
AU2007253424A1 (en) 2007-11-29
NZ572075A (en) 2011-11-25
US20100152256A1 (en) 2010-06-17
US7652169B2 (en) 2010-01-26
WO2007135080A2 (en) 2007-11-29
PT2024329E (en) 2013-11-04
WO2007135080A3 (en) 2008-01-10
US20090093530A1 (en) 2009-04-09
HRP20130989T1 (en) 2013-12-06

Similar Documents

Publication Publication Date Title
HUS1400051I1 (en) Pharmaceutical composition containing lurazidone
ITBO20050123A1 (en) GASTRORESISTIC PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMINA
DK1913001T3 (en) (R) -N-METHYLNALTREXON, METHODS OF SYNTHESIS AND PHARMACEUTICAL APPLICATION
IL190292A (en) Pyridopyrimidinone derivatives and pharmaceutical compositions comprising them
IL238308B (en) Pharmaceutical compositions containing azelastine
PL2939688T3 (en) Pharmaceutical compositions containing botulinum neurotoxin
IL197836A (en) Phlorizin analogs and pharmaceutical compositions comprising them
BRPI0511900A (en) pharmaceutical compositions
NO20075628L (en) Pharmaceutical formulations
IL194546A0 (en) Arylaminopyridine derivatives and pharmaceutical compositions containing them
IL187957A0 (en) Liquid pharmaceutical formulations of docetaxel
DK2024329T3 (en) (2R) -2 - [(4-SULPHONYL) AMINOPHENYL] PROPANAMIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IL187748A0 (en) Pharmaceutical compositions containing misoprostal
EP2001400A4 (en) ORAL PREPARATIONS OF GLYCYL-2-METHYLPROPYL-GLUTAMATE
IL187534A0 (en) Thiazole derivatives, use thereof and pharmaceutical compositions containing them
PT1850664E (en) FORMULATION OF CAPSULES
IL218745A0 (en) Pharmaceutical compositions containing roflumilast
IL187552A0 (en) Pharmaceutical compositions containing nebivolol
DK2038294T3 (en) 18-methyl-19-nor-androst-4-ene-17,17-spiro ether (18-methyl-19-nor-20-spirox-4-ene-3-one) and pharmaceutical compositions containing these
EP1890677A4 (en) Pharmaceutical compositions and use thereof
PL1951663T3 (en) (r)-arylkylamino derivatives and pharmaceutical compositions containing them
DK2094638T3 (en) 2-aryl-2-fluoropropanoic acids and derivatives and pharmaceutical compositions containing them
IL187026A0 (en) Substituted acrylamide derivatives and pharmaceutical compositions containing the same
DK1707564T3 (en) Indanyl-piperazine derivatives, processes for their preparation and pharmaceutical compositions containing them
DK1745786T3 (en) Neuroprotective compounds and pharmaceutical compositions comprising them